Pulse Pressure and Outcome in Kidney Transplantation: Results From the Collaborative Transplant Study
暂无分享,去创建一个
B. Krämer | G. Opelz | C. Süsal | B. Krüger | B. Döhler
[1] M. Palta,et al. The Association Between Renin-Angiotensin System Blockade and Long-term Outcomes in Renal Transplant Recipients: The Wisconsin Allograft Recipient Database (WisARD) , 2016, Transplantation.
[2] Christine A. White,et al. Ramipril versus placebo in kidney transplant patients with proteinuria: a multicentre, double-blind, randomised controlled trial. , 2016, The lancet. Diabetes & endocrinology.
[3] S. Solomon,et al. BP, cardiovascular disease, and death in the Folic Acid for Vascular Outcome Reduction in Transplantation trial. , 2014, Journal of the American Society of Nephrology : JASN.
[4] G. Opelz,et al. Renin-Angiotensin system blockers and cardiovascular death in kidney recipients. , 2014, Transplantation.
[5] G. Opelz,et al. Cardiovascular Death in Kidney Recipients Treated With Renin–Angiotensin System Blockers , 2013, Transplantation.
[6] A. Dominiczak,et al. 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension. , 2013, Journal of hypertension.
[7] G. L’italien,et al. The External Validation of the Cardiovascular Risk Equation for Renal Transplant Recipients: Applications to BENEFIT and BENEFIT-EXT Trials , 2013, Transplantation.
[8] I. Holme,et al. A Cardiovascular Risk Calculator for Renal Transplant Recipients , 2012, Transplantation.
[9] Mahboob Rahman,et al. Hemodynamic correlates of proteinuria in chronic kidney disease. , 2011, Clinical journal of the American Society of Nephrology : CJASN.
[10] J. Kaski,et al. Pulse pressure and progression of chronic kidney disease. , 2010, Journal of nephrology.
[11] R. Schmieder,et al. Candesartan improves blood pressure control and reduces proteinuria in renal transplant recipients: results from SECRET. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[12] P. Fesler,et al. Early High Pulse Pressure is Associated With Graft Dysfunction and Predicts Poor Kidney Allograft Survival , 2009, Transplantation.
[13] B. Pannier,et al. Cardiovascular risk as defined in the 2003 European blood pressure classification: the assessment of an additional predictive value of pulse pressure on mortality , 2008, Journal of hypertension.
[14] M. Zeier,et al. No improvement of patient or graft survival in transplant recipients treated with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers: a collaborative transplant study report. , 2006, Journal of the American Society of Nephrology : JASN.
[15] G. Heinze,et al. Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation. , 2006, Journal of the American Society of Nephrology : JASN.
[16] G. Opelz,et al. Improved Long‐Term Outcomes After Renal Transplantation Associated with Blood Pressure Control , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[17] Helmut Schulte,et al. Importance of arterial pulse pressure as a predictor of coronary heart disease risk in PROCAM. , 2005, European heart journal.
[18] M. Arias,et al. Association Between Pulse Pressure and Cardiovascular Disease in Renal Transplant Patients , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[19] I. Holme,et al. Fluvastatin Prevents Cardiac Death and Myocardial Infarction in Renal Transplant Recipients: Post‐Hoc Subgroup Analyses of the ALERT Study , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[20] Roberto Pastor-Barriuso,et al. Systolic Blood Pressure, Diastolic Blood Pressure, and Pulse Pressure: An Evaluation of Their Joint Effect on Mortality , 2003, Annals of Internal Medicine.
[21] C. Hengstenberg,et al. Cardiovascular Risk Factors and Estimated Risk for CAD in a Randomized Trial Comparing Calcineurin Inhibitors in Renal Transplantation , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[22] B. Brenner,et al. Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study. , 2003, Archives of internal medicine.
[23] M. Pfeffer,et al. Pulse pressure and cardiovascular disease-related mortality: follow-up study of the Multiple Risk Factor Intervention Trial (MRFIT). , 2002, JAMA.
[24] T. Risler,et al. Antihypertensive treatment for kidney transplant recipients , 2002 .
[25] R. Asmar,et al. Reference values for clinic pulse pressure in a nonselected population. , 2001, American journal of hypertension.
[26] Martin G. Larson,et al. Does the Relation of Blood Pressure to Coronary Heart Disease Risk Change With Aging?: The Framingham Heart Study , 2001, Circulation.
[27] B. Kasiske,et al. Explained and unexplained ischemic heart disease risk after renal transplantation. , 2000, Journal of the American Society of Nephrology : JASN.
[28] D. Levy,et al. Is pulse pressure useful in predicting risk for coronary heart Disease? The Framingham heart study. , 1999, Circulation.
[29] M. Joffe,et al. Blood pressure and the survival of renal allografts from living donors. , 2004, Journal of the American Society of Nephrology : JASN.
[30] G. Opelz,et al. Association of chronic kidney graft failure with recipient blood pressure. Collaborative Transplant Study. , 1998, Kidney international.